OCC_IP_Loop_Ny3

WHERE BUDDING BIOTECHS BLOOM

Oslo Cancer Cluster Incubator

A DYNAMIC, CREATIVE AND

PROFESSIONAL GROWTH ENVIRONMENT

OCC_IP_Loop_Ny1

A GATEWAY TO NORWEGIAN

ONCOLOGY INVESTOR POSSIBILITIES

LATEST NEWS

targovax_bruke

Vaccibody announces positive results

Vaccibody AS today announced that the cohort review committee as well as the independent data monitoring board have completed their review of the interim analysis of the results from the phase I dosing part of the multicentre trial VB C-01. The two committees recommended continuation of the trial into the expansion phase IIa.

PCI Biotech and Ultimovacs initiate research collaboration

Incubator_forside_liteTwo of the biotech companies in the Oslo Cancer Cluster, PCI Biotech and Ultimovacs, initiate research collaboration on cancer vaccination.
Read more >

SPACE FOR RENT

INCUBATOR BENEFITS

• Flexible office and lab space
• Plug and play
• Publicly funded incubator-services
• Global investor network
• Global pharma network
• One to one guiding & competence building
• Business development
• IP and regulatory insights
• Trainings seminars
• Co-localization

TAILORED LAB SPACE

• Your own lab space or lab
• Shared lab infrastructure
• Reduced costs
• Systematic support and maintenance

VIEW INCUBATOR VIDEO

OSLO CANCER CLUSTER INCUBATOR

© Copyright - Oslo Cancer Cluster - Incubator - Organization number: 998483506 - Design by Fete Typer